Categories AlphaGraphs, Retail

Trxade (MEDS) stock soars after a big top-line beat

Trxade's Q2 revenue grows 244% as pandemic drives demand for personal protective equipment

Trxade (NASDAQ: MEDS) on Monday posted second-quarter revenues that more-than-tripled to $6.6 million, primarily driven by higher sales of personal protective equipment (PPE) through its Integra Pharma unit. The top-line was way ahead of the average Wall Street consensus of $2.15 million in revenues.  

Meanwhile, the company swung to a loss of $0.07 per share, from a profit of $0.01 per share a year ago, as lower margins on the pandemic-driven products weighed on the bottom-line results. Analysts, were on average, expecting a profit of 1 cent per share.   

Trxade Group Q2 2020 earnings results.

Looking forward to listening to management/analyst comments on Q2 results? Get more insights from Trxade’s Q2 earnings conference call transcript

The big top-line beat sent the stock soaring 35% during after-market hours. The stock has gained 74% in the trailing 12 months.

Trxade, which brings together independent pharmacies under one umbrella through its web-based purchasing platform, was recently uplisted to Nasdaq. The company is now present in all 50 states and is rapidly adding pharmacies to its network.

In the second quarter, the Tampa, Florida-based firm added 325 new independent pharmacies to its network. The company now has approximately 11,725 registered pharmacy members.  CEO Suren Ajjarapu said:


“As we move through the second half of 2020, we are better positioned than ever to execute upon our vision of continued growth of the platform, driven by new independent pharmacies, new suppliers and distributors.”

Bonum Health and DelivMeds, Trxade’s telemedical portals, help independent pharmacies offer same-day delivery of drugs to around 15 million patients.

Later today, Trxade is set to hold its first post-earnings conference call.

Prior quarter performance

Trxade Group Q1 2020 earnings

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

2 thoughts on “Trxade (MEDS) stock soars after a big top-line beat

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Comment
Loading...

Cancel
Viewing Highlight
Loading...
Highlight
Close
Top